BRD4 and nut midline carcinoma: For example, translocation of bromodomain-containing protein 4 (BRD4) and formation of BRD4-NUTM1 fusion protein leads to a gain-of-function in the context of reading the histone acetylation in NUT midline carcinoma, and targeting BRD4 found effectively therapeutic in use [24].